Brain delivery of olanzapine by intranasal administration of transfersomal vesicles

Journal of Liposome Research

Volumn 22, Issue 4, 2012, Pages 336-345

  Salama, Hamed A ^a   Mahmoud, Azza A ^a   Kamel, Amany O ^b   Abdel Hady, Mayssa ^a   Awad, Gehanne A S ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b Ain Shams University   (Egypt)

Author keywords

Brain delivery; Intranasal; Olanzapine; Pharmacokinetic studies; Transfersomes; Vesicular systems

Indexed keywords

CETOMACROGOL; CREMOPHOR; DEOXYCHOLATE SODIUM; OLANZAPINE; PHOSPHATIDYLCHOLINE; POLIDOCANOL; SORBITAN STEARATE; SURFACTANT;

AREA UNDER THE CURVE; ARTICLE; BRAIN; COMPARATIVE STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, INTRANASAL; ANIMALS; BENZODIAZEPINES; CALORIMETRY, DIFFERENTIAL SCANNING; LIPOSOMES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS;

EID: 84870260367     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2012.700460     Document Type: Article

References (51)

1. Allen, T. M. (1981). A study of phospholipid interactions between high-density lipoproteins and small unilamellar vesicles. Biochim Biophys Acta 640:385-397.
2. Alsarra, I. A., Hamed, A. Y., Alanazi, F. K. (2008). Acyclovir liposomes for intranasal systemic delivery: development and pharmacokinetics evaluation. Drug Deliv 15:313-321.
3. Alsarra, I. A., Hamed, A. Y., Alanazi, F. K., El Maghraby, G. M. (2010). Vesicular systems for intranasal drug delivery. Neuromethods 45:175-203.
4. Bancroft, D. J., Gamble, M. (2007). Teory and practice of histological techniques, 7th ed. New York: Churchill Livingstone.
5. Bangham, A. D., Standish, M. M., Watkins, J. C. (1965). Difusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238-252.
6. Barenholz, Y. (2003). Relevancy of drug loading to liposomal formulation therapeutic efcacy. J Liposome Research 13:1-8. (Pubitemid 36378121)
7. Beasley, C. M., Jr., Hamilton, S. H., Crawford, A. M., Dellva, M. A., Tollefson, G. D., Tran, P. V., et al. (1997). Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial. Eur Neuropsychopharmacol 7:125-137. (Pubitemid 27240346)
8. Bymaster, F. P., Calligaro, D. O., Falcone, J. F., Marsh, R. D., Moore, N. A., Tye, N. C., et al. (1996). Radioreceptor binding profle of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96. (Pubitemid 26053226)
9. Callaghan, J. T., Bergstrom, R. F., Ptak, L. R., Beasley, C. M. (1999). Olanzapine. Pharmacokinetic and pharmacodynamic profle. Clin Pharmacokinet 37:177-193.
10. Cevc, G. (1991). Polymorphism of the bilayer membranes in the ordered phase and the molecular origin of the lipid pretransition and rippled lamellae. Biochim Biophys Acta 1062:59-69.
11. Comiskey, S. J., Heath, T. D. (1990). Serum-induced leakage of negatively charged liposomes at nanomolar lipid concentrations. Biochemistry 29:3626-3631. (Pubitemid 20142702)
12. Costantino, H. R., Illum, L., Brandt, G., Johnson, P. H., Quay, S. C. (2007). Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharma 337:1-24. (Pubitemid 46756063)
13. Di Colo, G., Zambito, Y., Zaino, C. (2008). Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues. J Pharm Sci 97:1652-1680.
14. Ding, X. W., Qi, R. X., Fu, Q., Piao, S. H. (2007). Pharmacokinetics and pharmacodynamics of sterylglucoside-modifed liposomes for levonorgestrel delivery via nasal route. Drug Deliv 14:101-104.
15. Dora, C. P., Singh, S. K., Kumar, S., Datusalia, A. K., Deep, A. (2010). Development and characterization of nanoparticles of glibenclamide by solvent displacement method. Acta Pol Pharm 67:283-290.
16. Dragicevic-Curic, N., Friedrich, M., Petersen, S., Scheglmann, D., Douroumis, D., Plass, W., et al. (2011). Assessment of fuidity of diferent invasomes by electron spin resonance and diferential scanning calorimetry. Int J Pharm 412:85-94.
17. Duangjit, S., Opanasopit, P., Rojanarata, T., Ngawhirunpat, T. (2011). Characterization and in vitro skin permeation of meloxicam-loaded liposomes versus transfersomes. J Drug Deliv 2011:418316.
18. El Maghraby, G. M., Williams, A. C., Barry, B. W. (2000). Oestradiol skin delivery from ultradeformable liposomes: refnement of surfactant concentration. Int J Pharm 196:63-74. (Pubitemid 30089515)
19. El Maghraby, G. M., Williams, A. C., Barry, B. W. (2004). Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm 276:143-161. (Pubitemid 38542995)
20. El Zaafarany, G. M., Awad, G. A., Holayel, S. M., Mortada, N. D. (2010). Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 397:164-172.
21. Fang, J. Y., Yu, S. Y., Wu, P. C., Huang, Y. B., Tsai, Y. H. (2001). In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215:91-99.
22. Fumagalli, F., Frasca, A., Racagni, G., Riva, M. A. (2009). Antipsychotic drugs modulate Arc expression in the rat brain. Eur Neuropsychopharmacol 19:109-115.
23. Gizurarson, S. (1990). Animal models for intranasal drug delivery studies. A review article. Acta Pharm Nord 2:105-122. (Pubitemid 20220363)
24. Gupta, P. N., Mishra, V., Rawat, A., Dubey, P., Mahor, S., Jain, S., et al. (2005a). Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm 293:73-82. (Pubitemid 40381082)
25. Gupta, P. N., Mishra, V., Singh, P., Rawat, A., Dubey, P., Mahor, S., et al. (2005b). Tetanus toxoid-loaded transfersomes for topical immunization. J Pharm Pharmacol 57:295-301. (Pubitemid 40314427)
26. Ishida, T., Harashima, H., Kiwada, H. (2002). Liposome clearance. Biosci Rep 22:197-224. (Pubitemid 35222732)
27. Johnson, P. H., Quay, S. C. (2005). Advances in nasal drug delivery through tight junction technology. Exp Opin Drug Deliv 2:281-298. (Pubitemid 41130883)
28. Khan, K. A., Rhodes, C. T. (1972). Efect of compaction pressure on the dissolution efciency of some direct compression systems. Pharm Acta Helv 47:594-607.
29. Kim, K. S., Pae, C. U., Chae, J. H., Bahk, W. M., Jun, T. (2001). An open pilot trial of olanzapine for delirium in the Korean population. Psychiatry Clin Neurosci 55:515-519. (Pubitemid 32938807)
30. Kulkarni, S. B., Betageri, G. V., Singh, M. (1995). Factors afecting microencapsulation of drugs in liposomes. J Microencapsul 12:229-246.
31. Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., Jeste, D. V. (2002). Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 63:892-909. (Pubitemid 35231730)
32. Lee, V. H., Yamamoto, A., Kompella, U. B. (1991). Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit Rev Ter Drug Carrier Syst 8:91-192.
33. Lin, H., Gebhardt, M., Bian, S., Kwon, K. A., Shim, C. K., Chung, S. J., et al. (2007). Enhancing efect of surfactants on fexofenadine.HCl transport across the human nasal epithelial cell monolayer. Int J Pharm 330:23-31. (Pubitemid 46097356)
34. Madhusoodanan, S., Brenner, R., Suresh, P., Concepcion, N. M., Florita, C. D., Menon, G., et al. (2000). Efcacy and tolerability of olanzapine in elderly patients with psychotic disorders: a prospective study. Ann Clin Psychiatry 12:11-18. (Pubitemid 30217808)
35. Maurya, S. D., Aggarwal, S., Tilak, V. K., Dhakar, R. C., Singh, A., Maurya, G. (2010). Enhanced transdermal delivery of indinavir sulfate via transfersomes. Int J Comp Pharma 1:1-7.
36. Mu, X., Zhong, Z. (2006). Preparation and properties of poly(vinly alcohol)-stabilized liposomes. Int J Pharm 318:55-61. (Pubitemid 43963300)
37. Nii, T., Ishii, F. (2005). Encapsulation efciency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int J Pharm 298:198-205. (Pubitemid 40828340)
38. Pardakhty, A., Varshosaz, J., Rouholamini, A. (2007). In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 328:130-141. (Pubitemid 44895483)
39. Schatzlein, A., Cevc, G. (1995). Skin penetration by phospholipid vesicles, transfersomes, as visualized by means of the confocal laser scanning microscopy. In: Cevc, C., Paltauf, F. (Eds.), Phospholipids, characterization, metabolism, and novel biological applications (pp. 191-209). Champaign, Illinois, USA: AOCS Press.
40. Seeman, P. (2010). Dopamine D2 receptors as treatment targets in schizophrenia. Clin Schizophr Relat Psychoses 4:56-73.
41. Senior, J. H. (1987). Fate and behavior of liposomes in vivo: a review of controlling factors. Crit Rev Ter Drug Carrier Syst 3:123-193. (Pubitemid 17219201)
42. Shahrokh, Z., Nichols, A. V. (1982). Particle size interconversion of human low density lipoproteins during incubation of plasma with phosphatidylcholine vesicles. Biochem Biophys Res Commun 108:888-895. (Pubitemid 13225882)
43. Srivastava, R. C., Nagappa, A. N. (2005). Application of surface activity in therapeutics, 1st ed. Amsterdam: Elsevier/North-Holland Biomedical Press.
44. Tengamnuay, P., Sahamethapat, A., Sailasuta, A., Mitra, A. K. (2000). Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts. Int J Pharm 197:53-67. (Pubitemid 30125777)
45. Trotta, M., Peira, E., Carlotti, M. E., Gallarate, M. (2004). Deformable liposomes for dermal administration of methotrexate. Int J Pharm 270:119-125. (Pubitemid 38077093)
46. Tune, L. (2002). Te role of antipsychotics in treating delirium. Curr Psychiatry Rep 4:209-212.
47. Vivek, K., Reddy, H., Murthy, R. S. (2007). Investigations of the efect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech 8:E83.
48. Vyas, T. K., Shahiwala, A., Marathe, S., Misra, A. (2005). Intranasal drug delivery for brain targeting. Curr Drug Deliv 2:165-175. (Pubitemid 40488626)
49. Young, J. T., Johnston, P. K., Pace, W. G., Mishra, K. A. (2004). Phospholipid-stabilized nanoparticles of cyclosporine A by rapid expansion from supercritical to aqueous solution. AAPS PharmSciTech 5:11.
50. Zaki, N. M., Awad, G. A., Mortada, N. D., Abd Elhady, S. S. (2007). Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci 32:296-307. (Pubitemid 350064481)
51. Zhang, Q., Jiang, X., Jiang, W., Lu, W., Su, L., Shi, Z. (2004). Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efciency to the brain. Int J Pharm 275:85-96. (Pubitemid 38481522)